Ryuzo Kawamori Selected Research

Ryuzo Kawamori Research Topics

Disease

93	Type 2 Diabetes Mellitus (MODY) 09/2021 - 01/2002
49	Insulin Resistance 01/2024 - 05/2003
20	Atherosclerosis 01/2014 - 08/2003
19	Hypertension (High Blood Pressure) 01/2024 - 07/2003
18	Hyperglycemia 03/2015 - 11/2002
17	Cardiovascular Diseases (Cardiovascular Disease) 01/2024 - 10/2005
12	Glucose Intolerance 01/2024 - 07/2003
11	Hypoglycemia (Reactive Hypoglycemia) 08/2017 - 08/2004
10	Body Weight (Weight, Body) 01/2023 - 12/2005
9	Diabetes Mellitus 01/2023 - 06/2005
8	Diabetic Nephropathies (Diabetic Nephropathy) 08/2010 - 01/2002
7	Stroke (Strokes) 01/2015 - 04/2009
7	Carotid Artery Diseases 01/2014 - 08/2003
5	Abdominal Obesity 01/2022 - 06/2006
5	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2021 - 08/2007
5	Hypercholesterolemia 05/2013 - 06/2007
4	Hyperinsulinism (Hyperinsulinemia) 10/2019 - 06/2006
4	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2019 - 12/2004
4	Inflammation (Inflammations) 08/2017 - 10/2006
4	Diabetes Complications 09/2013 - 07/2006
3	Sarcopenia 01/2024 - 12/2022
3	Prediabetic State (Prediabetes) 12/2022 - 10/2008
3	Obesity 09/2021 - 06/2006
3	Dyslipidemias (Dyslipidemia) 01/2015 - 01/2014
3	Albuminuria 03/2013 - 03/2003
3	Diabetic Retinopathy (Retinopathy, Diabetic) 07/2010 - 05/2005
3	Proteinuria 02/2010 - 12/2002
3	Coronary Disease (Coronary Heart Disease) 02/2010 - 12/2004
2	Osteophyte 12/2023 - 09/2023
2	Fatigue 01/2022 - 01/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2017 - 04/2010
2	Neuralgia (Stump Neuralgia) 01/2016 - 04/2011
2	Fatty Liver 03/2015 - 06/2006
2	Ischemic Stroke 01/2015 - 04/2009
2	Vascular System Injuries 06/2014 - 02/2011

Drug/Important Bio-Agent (IBA)

56	Insulin (Novolin)FDA Link 06/2023 - 05/2003
52	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 07/2003
23	LipidsIBA 01/2024 - 08/2003
14	Blood Glucose (Blood Sugar)IBA 05/2021 - 07/2003
9	Triglycerides (Triacylglycerol)IBA 01/2024 - 06/2006
9	Nonesterified Fatty Acids (NEFA)IBA 01/2024 - 06/2005
9	Antihypertensive Agents (Antihypertensives)IBA 02/2016 - 10/2006
9	Pioglitazone (Actos)FDA Link 01/2015 - 05/2007
9	Hypoglycemic Agents (Hypoglycemics)IBA 06/2014 - 11/2002
7	Metformin (Glucophage)FDA LinkGeneric 08/2017 - 06/2004
7	insulin aspart protamine drug combination 30:70 insulin aspartIBA 06/2013 - 01/2005
7	Insulin Glargine (Lantus)FDA Link 08/2008 - 01/2005
6	Rosuvastatin Calcium (Crestor)FDA Link 01/2014 - 01/2009
6	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2014 - 04/2005
6	Glycoside Hydrolase InhibitorsIBA 11/2013 - 06/2004
6	Nateglinide (Starlix)FDA LinkGeneric 06/2012 - 11/2002
6	voglibose (Basen)IBA 01/2011 - 11/2002
6	CreatinineIBA 11/2010 - 01/2002
5	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2021 - 01/2005
5	AlbuminsIBA 01/2017 - 04/2009
5	olmesartanIBA 02/2016 - 01/2008
5	Dipeptidyl-Peptidase IV InhibitorsIBA 01/2016 - 03/2010
4	Protons (Proton)IBA 12/2023 - 01/2013
4	ORALIT (ORS)IBA 01/2023 - 12/2004
4	LDL CholesterolIBA 01/2015 - 01/2009
4	oxidized low density lipoproteinIBA 01/2013 - 12/2004
4	Pravastatin (Pravachol)FDA LinkGeneric 01/2013 - 06/2007
4	Angiotensin Receptor AntagonistsIBA 01/2012 - 10/2004
4	candesartanIBA 02/2011 - 06/2006
4	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 09/2009 - 10/2006
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2022 - 01/2009
3	AdiponectinIBA 01/2021 - 02/2012
3	Biomarkers (Surrogate Marker)IBA 07/2020 - 06/2010
3	HDL CholesterolIBA 01/2019 - 12/2009
3	repaglinide (Prandin)FDA Link 03/2016 - 06/2012
3	Hemoglobins (Hemoglobin)IBA 01/2015 - 05/2005
3	Atorvastatin (Lipitor)FDA Link 05/2013 - 06/2005
3	azelnidipineIBA 03/2013 - 12/2007
3	Amlodipine (Norvasc)FDA LinkGeneric 01/2012 - 10/2006
3	PotassiumIBA 08/2011 - 09/2008
3	Cilostazol (Pletal)FDA LinkGeneric 06/2010 - 12/2004
3	glimepiride (Amarel)FDA LinkGeneric 02/2010 - 01/2008
3	CholesterolIBA 09/2009 - 08/2003
3	ElementsIBA 09/2009 - 06/2006
3	InsulinsIBA 08/2009 - 01/2005
3	biphasic human insulin 30IBA 08/2009 - 01/2005
3	epalrestatIBA 01/2009 - 07/2006
3	Telmisartan (Micardis)FDA Link 04/2008 - 06/2007
3	Short-Acting InsulinIBA 12/2007 - 01/2005
3	Isophane Insulin (NPH Insulin)FDA Link 12/2007 - 01/2005
3	Angiotensin II Type 1 Receptor BlockersIBA 04/2007 - 06/2006
3	Insulin Aspart (NovoLog)FDA Link 02/2007 - 01/2005
3	Transcription Factors (Transcription Factor)IBA 11/2006 - 01/2005
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2005
2	DiglyceridesIBA 01/2023 - 12/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 09/2021 - 01/2021
2	6- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA 09/2021 - 01/2021
2	Sitagliptin Phosphate (Januvia)FDA Link 03/2016 - 03/2015
2	Duloxetine Hydrochloride (Cymbalta)FDA Link 01/2016 - 04/2011
2	Fatty Acids (Saturated Fatty Acids)IBA 09/2014 - 05/2008

Therapy/Procedure

33	Therapeutics 03/2016 - 12/2004
25	Glycemic Control 08/2017 - 08/2003
3	Exercise Therapy (Therapy, Exercise) 08/2017 - 06/2005
2	Long-Term Care 01/2023 - 01/2019
2	Surgical Amputation (Amputations) 01/2018 - 02/2010